cinacalcet has been researched along with Hypercalciuria in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flechner, SM; Seager, CM; Srinivas, TR | 1 |
| Bleich, M; Gong, Y; Himmerkus, N; Hou, J; Plain, A | 1 |
| Baorda, F; Campo, MR; Cignarelli, M; Cinque, L; Conserva, A; Guarnieri, V; Lamacchia, O; Mastromatteo, E; Scillitani, A | 1 |
| Abreu, C; Castro, JC; Díez, JJ; Iglesias, P | 1 |
| Courbebaisse, M; Diet, C; Friedlander, G; Legendre, C; Mamzer, MF; Martinez, F; Noel, LH; Prié, D; Thervet, E; Timsit, MO | 1 |
| Durand, D; Esposito, L; Gennero, I; Kamar, N; Mehrenberger, M; Rostaing, L | 1 |
6 other study(ies) available for cinacalcet and Hypercalciuria
| Article | Year |
|---|---|
Development of nephrolithiasis in a renal transplant patient during treatment with Cinacalcet.
Topics: Adult; Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalciuria; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Naphthalenes; Nephrolithiasis; Tomography, X-Ray Computed | 2013 |
Epigenetic regulation of microRNAs controlling CLDN14 expression as a mechanism for renal calcium handling.
Topics: Animals; Calcium; Cinacalcet; Claudins; Epigenesis, Genetic; Gene Expression Regulation; Histone Deacetylase Inhibitors; Hypercalciuria; Hypocalcemia; Hypoparathyroidism; Kidney; Magnesium; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Naphthalenes; Receptors, Calcium-Sensing | 2015 |
A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
Topics: Adult; Aged; Blotting, Western; Calcimimetic Agents; Cinacalcet; Genetic Markers; Humans; Hypercalcemia; Hypercalciuria; Male; Naphthalenes; Parathyroid Hormone; Pedigree; Point Mutation; Receptors, Calcium-Sensing; Treatment Outcome | 2014 |
[Long-term combined treatment with cinacalcet and bisphosphonates in persistent primary hyperparathyroidism after surgery].
Topics: Alendronate; Bone Density Conservation Agents; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hypercalciuria; Hyperparathyroidism, Primary; Hyperphosphatemia; Middle Aged; Naphthalenes; Osteoporosis; Postoperative Complications | 2012 |
Effects of cinacalcet in renal transplant patients with hyperparathyroidism.
Topics: Adult; Aged; Biopsy; Calcimimetic Agents; Calcium; Chi-Square Distribution; Cinacalcet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hypercalciuria; Hyperparathyroidism; Kidney; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Nephrocalcinosis; Parathyroid Hormone; Phosphates; Vitamin D; Young Adult | 2012 |
Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient.
Topics: Cinacalcet; Female; Humans; Hypercalciuria; Hyperparathyroidism; Kidney Transplantation; Middle Aged; Naphthalenes; Parathyroid Hormone; Renal Agents | 2007 |